Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Control Bionics Ltd. ( (AU:CBL) ) just unveiled an update.
Control Bionics Ltd. announced the issuance of 50,000,000 fully paid ordinary shares without disclosure under the Corporations Act. This move indicates the company’s compliance with relevant legal provisions and suggests a strategic effort to enhance its financial position, potentially impacting its market operations and stakeholders.
The most recent analyst rating on (AU:CBL) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on Control Bionics Ltd. stock, see the AU:CBL Stock Forecast page.
More about Control Bionics Ltd.
Control Bionics Ltd. operates in the technology industry, focusing on developing and providing assistive technology solutions. The company specializes in creating products that enable individuals with disabilities to communicate and interact with their environment.
Average Trading Volume: 1,138,638
Technical Sentiment Signal: Buy
Current Market Cap: A$26.51M
Find detailed analytics on CBL stock on TipRanks’ Stock Analysis page.